Acute posttransfusion hepatitis C: Identification of a common hepatitis C virus strain in donor and recipient using polymorphism analysis

Infection

Volumn 29, Issue 1, 2001, Pages 40-43

  Chinchai, T ^a   Noppornpanth, S ^a   Theamboonlers, A ^a   Chongsrisawat, V ^a   Poovorawan, Y ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Acute hepatitis C; Hepatitis C virus RNA; Posttransfusion; Restriction fragment length polymorphism; Reverse transcription PCR

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; COMPLEMENTARY DNA; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CASE REPORT; CHILD; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NONHUMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS HEPATITIS;

ANTIBODIES, VIRAL; BLOOD TRANSFUSION; CARRIER STATE; CHILD; DENGUE HEMORRHAGIC FEVER; GENE AMPLIFICATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0035115931     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-001-0063-8     Document Type: Article

References (19)

1. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy
2. Efficacy of combined interferon and ribavirin for treatment of hepatitis C
3. The natural history of hepatitis C virus infection: Host, viral and environmental factors
4. Hepatitis C in hospital employees with needlestick injuries
5. Natural history of hepatitis C
6. The prevalence of hepatitis C virus antibody in high risk group of Thai children and adults
7. High prevalence of hepatitis C infection among blood donors in Northeastern Thailand
8. A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C
9. Interferon-alpha in acute posttransfusion hepatitis C: A randormized, controlled trial
10. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotypes are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C
11. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C
12. High-dose interferon-alpha 2b treatment prevents chronicity in acute hepatitis C. A pilot study
13. Association of hepatitis viruses with hepatocellular carcinoma in Thailand
14. Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay
15. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region
16. Early therapy with interferon for acute hepatitis C acquired through a needlestick
17. Complete response to twice-a-day interferon beta with standard interferon-alpha therapy in acute hepatitis C after a needle-stick
18. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
19. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus